SWBI Stock Analysis: Smith & Wesson Brands | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 594m USD | 12M Return: 73% | US8317541063 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.65M
EPS Trend: -70.0%
Qual. Beats: 2
Rev. Trend: -14.1%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Smith & Wesson Brands (SWBI) is a U.S.-based designer, manufacturer, and global seller of firearms, with a portfolio that spans handguns (revolvers and pistols), long guns (modern sporting rifles, pistol-caliber carbines, and lever-action rifles), handcuffs, suppressors, and related accessories. The company also operates a contract manufacturing segment offering forging, heat-treating, machining, plating, and custom plastic injection molding services to third parties.
Its customer base spans consumer end markets - hunters, sport shooters, collectors, and home-defense buyers - as well as institutional channels including law enforcement, private security, and military agencies. Products reach customers through independent dealers, retailers, direct-to-consumer channels, and range operations, supported by print, broadcast, digital, and social media advertising. The company was founded in 1852 and is headquartered in Maryville, Tennessee.
The firearms sector is heavily regulated at the federal level (ATF oversight, with the National Firearms Act governing items such as suppressors) and subject to state-level purchasing and background-check rules, which can drive demand volatility. SWBI is classified in the Consumer Discretionary sector under Leisure Products and trades as a small-cap stock following its 1998 listing.
- Election cycle drives handgun and modern sporting rifle sales
- Margin expansion follows inventory destocking and lower input costs
- Suppressor category growth offsets declining hunting rifle demand
| Net Income: 24.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 15.28 > 1.0 |
| NWC/Revenue: 32.48% < 20% (prev 47.22%; Δ -14.75% < -1%) |
| CFO/TA 0.22 > 3% & CFO 113.5m > Net Income 24.5m |
| Net Debt (81.1m) to EBITDA (66.9m): 1.21 < 3 |
| Current Ratio: 3.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.5m) vs 12m ago 2.74% < -2% |
| Gross Margin: 27.44% > 18% (prev 26.54%; Δ 0.90% > 0.5%) |
| Asset Turnover: 102.3% > 50% (prev 84.99%; Δ 17.30% > 0%) |
| Interest Coverage Ratio: 5.87 > 6 (EBIT TTM 36.3m / Interest Expense TTM 6.19m) |
| A: 0.34 (Total Current Assets 247.5m - Total Current Liabilities 68.4m) / Total Assets 523.3m |
| B: 0.71 (Retained Earnings 370.5m / Total Assets 523.3m) |
| C: 0.07 (EBIT TTM 36.3m / Avg Total Assets 539.0m) |
| D: 2.50 (Book Value of Equity 373.7m / Total Liabilities 149.6m) |
| Altman-Z'' = 7.63 = AAA |
| DSRI: 0.67 (Receivables 33.0m/42.2m, Revenue 551.4m/471.4m) |
| GMI: 0.97 (GM 26.54% / 27.44%) |
| AQI: 0.88 (AQ_t 0.06 / AQ_t-1 0.07) |
| SGI: 1.17 (Revenue 551.4m / 471.4m) |
| TATA: -0.17 (NI 24.5m - CFO 113.5m) / TA 523.3m) |
| Beneish M = -3.30 (Cap -4..+1) = AA |
As of November 09, 2026, the stock is trading at USD 14.47 with a total of 835,840 shares traded. Over the past week, the price has changed by +9.79%, over one month by -0.34%, over three months by +0.45% and over the past year by +72.98%.
Current recommended Stop Loss: 13.80 (which is 4.6% or 1.3 ATR below the current price).
Smith & Wesson Brands has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy SWBI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.3 | 19.2% |
P/E Trailing = 24.537
P/E Forward = 11.7786
P/S = 1.0776
P/B = 1.5814
P/EG = 0.8406
Revenue TTM = 551.4m USD
EBIT TTM = 36.3m USD
EBITDA TTM = 66.9m USD
Long Term Debt = 39.2m USD (from longTermDebt, last quarter)
Short Term Debt = 1.90m USD (from shortTermDebt, last quarter)
Debt = 106.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 33.6m
Net Debt = 81.1m USD (calculated: Debt 106.3m - CCE 25.2m)
Enterprise Value = 675.2m USD (594.1m + Debt 106.3m - CCE 25.2m)
Interest Coverage Ratio = 5.87 (Ebit TTM 36.3m / Interest Expense TTM 6.19m)
EV/FCF = 8.23x (Enterprise Value 675.2m / FCF TTM 82.0m)
FCF Yield = 12.15% (FCF TTM 82.0m / Enterprise Value 675.2m)
FCF Margin = 14.88% (FCF TTM 82.0m / Revenue TTM 551.4m)
Net Margin = 4.44% (Net Income TTM 24.5m / Revenue TTM 551.4m)
Gross Margin = 27.44% ((Revenue TTM 551.4m - Cost of Revenue TTM 400.1m) / Revenue TTM)
Gross Margin QoQ = 28.66% (prev 29.76%)
Tobins Q-Ratio = 1.29 (Enterprise Value 675.2m / Total Assets 523.3m)
Interest Expense / Debt = 5.83% (Interest Expense 6.19m / Debt 106.3m)
Taxrate = 26.24% (8.71m / 33.2m)
NOPAT = 26.8m (EBIT 36.3m * (1 - 26.24%))
Current Ratio = 3.62 (Total Current Assets 247.5m / Total Current Liabilities 68.4m)
Debt / Equity = 0.28 (Debt 106.3m / totalStockholderEquity, last quarter 373.7m)
Debt / EBITDA = 1.21 (Net Debt 81.1m / EBITDA 66.9m)
Debt / FCF = 0.99 (Net Debt 81.1m / FCF TTM 82.0m)
Total Stockholder Equity = 369.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.54% (Net Income 24.5m / Total Assets 523.3m)
RoE = 6.63% (Net Income TTM 24.5m / Total Stockholder Equity 369.2m)
RoCE = 8.90% (EBIT 36.3m / Capital Employed (Equity 369.2m + L.T.Debt 39.2m))
RoIC = 6.21% (NOPAT 26.8m / Invested Capital 431.5m)
WACC = 6.68% (E(594.1m)/V(700.5m) * Re(7.11%) + D(106.3m)/V(700.5m) * Rd(5.83%) * (1-Tc(0.26)))
Discount Rate = 7.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -16.91 | Cagr: -0.55%
[DCF] Terminal Value 77.97% ; FCFF base≈50.1m ; Y1≈57.4m ; Y5≈84.5m
[DCF] Fair Price = 26.55 (EV 1.27b - Net Debt 81.1m = Equity 1.19b / Shares 44.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -70.01 | EPS CAGR: -35.37% | SUE: 1.95 | # QB: 2
Revenue Correlation: -14.05 | Revenue CAGR: -0.83% | SUE: 1.14 | # QB: 3
EPS current Quarter (2026-10-31): EPS=0.08 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS next Quarter (2027-01-31): EPS=0.12 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS current Year (2027-04-30): EPS=0.55 | Chg30d=+17.02% | Revisions=+25% | GrowthEPS=+34.2% | GrowthRev=+6.8%
EPS next Year (2028-04-30): EPS=0.60 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+9.1% | GrowthRev=+2.2%